To the many complications of maintenance dialysis (1-3) must now be added the possibility of an increased risk of cancer (4) . Although early reports stressed the occurrence of tumors in immunosuppressed renal transplant patients, some of these malignancies were discovered so early after surgery as to give rise to the suspicion that they had developed during the period of uremia preceding the transplantation (5, 6) . In 1975 Matas et al provided the first convincing evidence of a link between uremia and malignancy, when they found nine cancers among 46 patients in the period of time they were uremic (3-36 months) (4). The 1.4 percent incidence rate was seven time higher than the expected yearly incidence rate in the agematched general population.
Although a few reports from Australia (7), Great Britain (8), France (9) , and the USA (10) have also recently appeared, it remains to be proven beyond doubt that cancer is frequent among uremic patients. The controversy about cancer in uremic is due in part to inadequate statistical analyses. Kinlen and coworkers (11) have pointed out that in previous studies the observed number of cancers was not compared with the expected number in a matched control population (4, 7, 8) . The larger series, such as the National (12) and European Dialysis Registries (3), give neither the time at risk and duration of exposure to uremia, the time at risk and duration of exposure to uremia, nor the necessary data about non-lethal cancers. In one study (8) the cancer incidence rate was incorrectly compared to death rates for the general population, thus invalidating any statistical conclusions. Skin cancers are also frequently included in these reports (7, 8) , thus introducing a bias toward detecting more tumors in these patients, who are examined more frequently than the control population.
In an attempt to clarify this issue, we examined the records of 151 patients receiving hemodialysis for an average of 66 months at the Seattle Veterans Administration Medical Center (13) . The duration of exposure to uremia and dialysis, age, sex, county of residence, and smoking history were determined in all cases. Nine cancers were found among 148 male patients, and six of these patients died from the malignancy. This finding of nine cancers is significantly higher (p < .0137) than the Cancer, uremia and hemodialysis expected 3.6 cancers for exposure-specific and agespecific controls of the same sex in the geographical area surrounding Seattle. This area was chosen as control since malignancy rates are reportedly higher than in most areas of the United States. This finding of a high incidence of cancer among our patients is striking, because rigid inclusion criteria were used. First, since only 3 female patients were present, they were excluded from statistical analysis. However, two of these three women developed carcinoma of the breast during the study period. Second, three cases of skin cancer were excluded. Third, the possible effect of smoking was also evaluated. Patients were dichotomized into smoking and nonsmoking groups and the expected number of cancers was generated for each separate group. We found that eight of the nine patients with cancer smoked, whereas the expected number of cancers among patients who smoked was 3.21 (p < .0168). By contrast, the expected number among nonsmokers was only 0.84, suggesting a risk of cancer in smokers. This is a good indication that the risk of cancer is particularly high compared to the sex-and age-matched population.
Our patients developed a variety of cancers (lungs, pancreas, breast, kidney), that of the lung being the most frequent. This finding is in agreement with the previous repart of Matas et al. (4) and is compatible with the concept of immunologic surveillance as a major defense against neoplastic cells (14) . This concept predicts that immunosuppressed hosts should be susceptible to a great variety of neoplasms. In contrast, Kinlen et al. (11) found only an excess of non-Hodgkins lymphoma among their patients. Therefore, while cancer seemed inordinately frequent among our patients, further data will be necessary to confirm these findings and to determine the pattern of malignancy in uremia.
It was also observed that just as in the transplant recipients, many cancers in our unit likewise occured during the first or second year of dialysis. This suggests that some of these cancers may have been present during the period of uremia preceding dialysis.
Thus, the evidence accumulated so far supports the occurrence on inordinately high incidence of malignancies in patients with long-standing uremia. Further work on this subject is needed. At present, a controlled, multicenter, prospective study of this problem is being carried out by I. Penn and D. Ogden at the Universities of Colorado and Arizona, respectively. Particular attention to the size of the population at risk, duration of exposure to dialysis and uremia, and consideration of smoking history should be essential pieces of information in such a study. Yet should these data be confirmed, cancer will have to be added to the list of events that shorter survival in uremia. In the meantime it would seem wise to strongly discourage smoking among dialysis patients. A 119 striking finding in our study was that the risk of cancer was particularly high in those patients who smoked.
